Corrigendum to ‘MPN-395: efficacy and safety of ≤200 mg avapritinib in patients with advanced systemic mastocytosis : pooled results from the phase 1 EXPLORER and interim phase 2 PATHFINDER studies’ [Clinical Lymphoma Myeloma & Leukemia 21S1 (2021) S367-S368]: corrigendum
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
April 2022
|
| In: |
Clinical lymphoma, myeloma & leukemia
Year: 2022, Volume: 22, Issue: 4, Pages: 276-276 |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2021.12.002 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.clml.2021.12.002 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S215226502102471X 
|
| Author Notes: | Deepti Radia, Daniel J. DeAngelo, Michael W. Deininger, Andreas Reiter, Jayita Sen, Hui-Min Lin, Sasa Dimitrijevic, Jason Gotlib |
| Item Description: | Online verfügbar: 31. Januar 2022, Artikelversion: 29. März 2022 Gesehen am 20.08.2024 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2021.12.002 |